Estudos Científicos

Study comparing Opdivo (nivolumab) to chemotherapy in treatment naïve advanced melanoma patients
Marks first PD-1 Immune checkpoint inhibitor to demonstrate a survival benefit in a phase 3 trial
19/11/2014 - 17:42
Opdivo demonstrated superior overall survival vs. dacarbazine with a one-year survival rate of 73% vs. 42% and a 58% decrease...
Statistically Significant Results from the First Part of the Phase 3 ANNEXA™
A Studies of Investigational Andexanet Alfa with Eliquis (apixaban)
18/11/2014 - 17:12
Andexanet Alfa Rapidly Reversed the Anticoagulant Effect of the Factor Xa Inhibitor Eliquis Among All Study Participants. Data...
Phase 3 UNITY trials demonstrate high cure rates for investigational
All-oral Daclatasvir TRIO fixed-dose combination in genotype 1 Hepatitis C patients, including those with cirrhosis
11/11/2014 - 17:54
Daclatasvir TRIO achieves 98% cure rate in treatment-naïve and 93% cure rate in treatment-experienced genotype 1 patients with...
Novos dados do ensaio ENDORSE demonstram
Resultados positivos da administração continuada de Tecfidera® durante 5 anos
01/10/2014 - 13:10
Novos dados da extensão do estudo de fase III ENDORSE promovido pela Biogen Idec demonstram que o Tecfidera® (fumarato de...
Subgroup Analysis of ENGAGE AF-TIMI 48 Explores
Relationship Between Edoxaban Dose, Concentration, Anti- Factor Xa Activity and Outcomes
12/09/2014 - 15:48
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced data from a subgroup analysis of the phase 3 ENGAGE AF...
Papel do Enfermeiro
Reabilitação Psicossocial Doente Inimputável
Reabilitação Psicossocial do Doente Inimputável
18/07/2014 - 12:46
Dar a conhecer a realidade psicopatológica e jurídico-penal do doente inimputável, o seu processo de reabilitação psicossocial,...
Demonstrates Superior Overall Survival Compared to Dacarbazine
Phase 3 First-Line Melanoma Study of Nivolumab, an Investigational PD-1 Checkpoint Inhibitor
02/07/2014 - 15:09
Bristol-Myers Squibb Company (NYSE:BMY) announced that a randomized blinded comparative Phase 3 study evaluating nivolumab...
A Randomized Clinical Trial
Prophylactic Use of a Probiotic in the Prevention of Colic, Regurgitation, and Functional Constipation
02/06/2014 - 15:53
To investigate whether oral supplementation with Lactobacillus reuteri DSM 17938 during the first 3 months of life can reduce...
Satisfação dos clientes com os Cuidados de Enfermagem de Reabilitação:
Contributo para a validação do Questionário SNQ-10
28/05/2014 - 16:02
A satisfação do cliente constitui um indicador preponderante para aferir a qualidade dos cuidados de enfermagem de reabilitação...
In combination with statins in patients with high cholesterol
Amgen Announces Positive Top-Line Results From Phase 3 LAPLACE-2 Trial Of Evolocumab
31/03/2014 - 16:35
Amgen Announces Positive Top-Line Results From Phase 3 LAPLACE-2 Trial Of Evolocumab (AMG 145) In Combination With Statins In...

Páginas